DK200100402A - Process for removing desmethyl citalopram from a citalopram product - Google Patents
Process for removing desmethyl citalopram from a citalopram product Download PDFInfo
- Publication number
- DK200100402A DK200100402A DK200100402A DKPA200100402A DK200100402A DK 200100402 A DK200100402 A DK 200100402A DK 200100402 A DK200100402 A DK 200100402A DK PA200100402 A DKPA200100402 A DK PA200100402A DK 200100402 A DK200100402 A DK 200100402A
- Authority
- DK
- Denmark
- Prior art keywords
- citalopram
- amide
- crude
- product
- formula
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
Description
reaktionblandingen underkastes derefter en syre/base vask og/eller krystallisering og rekrystallisering af citalopram for at fjerne amiderne, dannet i den rå citalopramblanding; og det fremkomne citalopramprodukt renses eventuelt yderligere, oparbejdes og isoleres som basen eller et farmaceutisk acceptabelt salt deraf.the reaction mixture is then subjected to an acid / base wash and / or crystallization and recrystallization of citalopram to remove the amides formed in the crude citalopram mixture; and the resulting citalopram product is optionally further purified, worked up and isolated as the base or a pharmaceutically acceptable salt thereof.
KRAVREQUIREMENTS
1. En fremgangsmåde til fjernelse af desmethyl citalopram med formlenA process for removing desmethyl citalopram of the formula
VIII) fra et råt produkt indeholdende citalopram med formlenVIII) from a crude product containing citalopram of the formula
(I) omfattende eventuelt at underkaste det rå citalopramprodukt indeholdende desmethylcitalopram urenheden en indledende rensning og efterfølgende at behandle det rå produkt med et middel, der danner en amid eller en amid-lignende gruppe, valgt blandt midlerne med formlerne (a), (b) eller (c):(I) comprising optionally subjecting the crude citalopram product containing the desmethylcitalopram impurity to initial purification and subsequently treating the crude product with an agent forming an amide or an amide-like group selected from the agents of formulas (a), (b) or (c):
hvor X er halogen eller en gruppe O-CO-R’, Hal er halogen, Y er O eller S, W er O, NH eller S og R, R’, R” og R’” hver især vælges blandt gruppen bestående af hydrogen, alkyl og eventuelt substitueret aryl eller aralkyl; reaktionblandingen underkastes derefter en syre/base vask og/eller krystallisering og rekrystal li sering af citalopram for at fjerne amiderne, dannet i den rå citalopramblanding; og det fremkomne citalopramprodukt renses eventuelt yderligere, oparbejdes og isoleres som basen eller et farmaceutisk acceptabelt salt deraf.wherein X is halogen or a group O-CO-R ', Hal is halogen, Y is O or S, W is O, NH or S and R, R', R 'and R' 'are each selected from the group consisting of hydrogen, alkyl and optionally substituted aryl or aralkyl; the reaction mixture is then subjected to an acid / base wash and / or crystallization and recrystallization of citalopram to remove the amides formed in the crude citalopram mixture; and the resulting citalopram product is optionally further purified, worked up and isolated as the base or a pharmaceutically acceptable salt thereof.
2. En fremgangsmåde ifølge krav 1, hvori det rå citalopram produkt fremstilles ved at underkaste en forbindelse med formlen ΠA process according to claim 1, wherein the crude citalopram product is prepared by subjecting a compound of formula Π
(Π) hvori Z er iod, brom, chlor eller CF3-(CF2)n-S02-0-, hvor n er 0,1, 2, 3,4,5, 6, 7 eller 8, en cyanidudskiftningsreaktion med en cyanidkilde.(Π) wherein Z is iodine, bromine, chlorine or CF3 - (CF2) n-SO2-0-, where n is 0.1, 2, 3,4,5, 6, 7 or 8, a cyanide replacement reaction with a cyanide source .
3. Processen ifølge krav 1-2 kendetegnet ved, at midlet, der danner et amid eller en amidlignende gruppe, er et middel med formlen R-CO-X, hvori R og X er som defineret i krav 1.The process according to claims 1-2, characterized in that the agent forming an amide or an amide-like group is an agent of the formula R-CO-X, wherein R and X are as defined in claim 1.
4. Processen ifølge krav 3 kendetegnet ved, at midlet, der danner et amid eller en Amid-lignende gruppe, er et carboxylsyreanhydrid eller acylhalogenid.The process according to claim 3, characterized in that the agent forming an amide or an amide-like group is a carboxylic anhydride or acyl halide.
5. Processen ifølge krav 4 kendetegnet ved, at midlet, der danner et amid eller en amid-lignende gruppe, er et eddikesyreanhydrid 6. Processen ifølge krav 4 kendetegnet ved, at midlet, der danner et amid eller en amid-lignende gruppe, er et acylchlorid, fortrinsvis acetylchlorid.The process according to claim 4 characterized in that the agent forming an amide or an amide-like group is an acetic anhydride 6. The process according to claim 4 characterized in that the agent forming an amide or an amide-like group is an acyl chloride, preferably acetyl chloride.
7. Processen ifølge et hvilket som helst af kravene 2-6 kendetegnet ved, at Z er Br og cyanidreaktionen udføres ved en reaktion med kobbercyanid i et passende opløsningsmiddel.The process according to any one of claims 2-6, characterized in that Z is Br and the cyanide reaction is carried out by a reaction with copper cyanide in a suitable solvent.
8. Processen ifølge et hvilket som helst af kravene 2-6 kendetegnet ved, at Z er iod, brom, chlor eller CF3-(CF2)n-S02-0-, hvor n er 0,1,2,3,4, 5,6,7 eller 8, og cyanidudskiftningsreaktionen udføres med en cyanidkilde i nærvær af en palladiumkatalysator og en katalytisk mængde af Cu+ eller Zn2^.The process according to any one of claims 2-6, characterized in that Z is iodine, bromine, chlorine or CF3- (CF2) n -SO2-0-, where n is 0,1,2,3,4, 5,6,7 or 8, and the cyanide replacement reaction is carried out with a cyanide source in the presence of a palladium catalyst and a catalytic amount of Cu + or Zn 2
9. Processen ifølge i hvilket som helst af kravene 2-6 kendetegnet ved, at Z er iod, brom, chlor eller CF3-(CF2)n-S02-0-, hvor n er 0,1, 2, 3,4, 5, 6, 7 eller 8, og cyanidudskifningsreaktionen udføres ved reaktion med Zn(CN)2 i nærvær af en palladiumkatalysator.The process according to any one of claims 2-6, characterized in that Z is iodine, bromine, chlorine or CF3- (CF2) n -SO2-0-, where n is 0.1, 2, 3.4, 5, 6, 7 or 8 and the cyanide exchange reaction is carried out by reaction with Zn (CN) 2 in the presence of a palladium catalyst.
10. Processen ifølge krav 9 kendetegnet ved, at Z er Br.The process according to claim 9, characterized in that Z is Br.
11. Processen ifølge et hvilket som helst af kravene 2-6 kendetegnet ved, at Z er Cl eller Br og at cyanidudskiftningsreaktionen udføres med en cyanidkilde i nærvær af en nikkelkatalysator, eventuelt i nærvær af en katalytisk mængde af Cu+ eller Zn2+.The process according to any of claims 2-6, characterized in that Z is Cl or Br and the cyanide exchange reaction is carried out with a cyanide source in the presence of a nickel catalyst, optionally in the presence of a catalytic amount of Cu + or Zn2 +.
12. Processen ifølge krav 11 kendetegnet ved, at Z er Cl.The process according to claim 11, characterized in that Z is Cl.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK200100402A DK174018B1 (en) | 2000-12-22 | 2001-03-08 | Process for removing desmethylcitalopram from a citalopram product |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK200001929 | 2000-12-22 | ||
| DKPA200001929 | 2000-12-22 | ||
| DK200100402 | 2001-03-08 | ||
| DK200100402A DK174018B1 (en) | 2000-12-22 | 2001-03-08 | Process for removing desmethylcitalopram from a citalopram product |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK174018B1 DK174018B1 (en) | 2002-04-22 |
| DK200100402A true DK200100402A (en) | 2002-04-22 |
Family
ID=26068932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK200100402A DK174018B1 (en) | 2000-12-22 | 2001-03-08 | Process for removing desmethylcitalopram from a citalopram product |
Country Status (1)
| Country | Link |
|---|---|
| DK (1) | DK174018B1 (en) |
-
2001
- 2001-03-08 DK DK200100402A patent/DK174018B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DK174018B1 (en) | 2002-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3798982B2 (en) | Method for producing pure citalopram | |
| JP2014514292A (en) | Reductive amination process for producing dronedarone using amine intermediate compounds | |
| JP2014514291A (en) | Method for producing dronedarone by mesylation | |
| JP2004256490A (en) | Method for producing trans-cyclohexane derivative | |
| TW202000643A (en) | Process for the preparation of a nitric oxide donating prostaglandin analogue | |
| DK200100402A (en) | Process for removing desmethyl citalopram from a citalopram product | |
| JP2018502164A (en) | Preparation of indamine amine derivatives and novel synthetic intermediates | |
| JP2004323433A (en) | Method for producing 5'-acyloxy nucleoside compound | |
| CA2930089C (en) | Fingolimod hydrochloride process | |
| JP3059007B2 (en) | Method for producing 1- (2-carboxyphenyl) indazole derivative | |
| JP2706554B2 (en) | 4-trifluoromethylaniline derivative and method for producing the same | |
| JP2007023005A (en) | Method of manufacturing milnacipran hydrochloride | |
| JP2004231521A (en) | Method for synthesizing 3-chloro-5-nitrotoluene | |
| KR20180101396A (en) | Process for producing acid halide solution and process for producing monoester compound | |
| EP0628024A4 (en) | Synthesis of ioversol using a minimal excess of acetoxyacetylchloride. | |
| JP2608761B2 (en) | Method for producing 7-bromo-β-carboline derivative and intermediate thereof | |
| JPH05221947A (en) | Production of cyclopropane derivative | |
| JPH0625208A (en) | Reagent for resolving racemic modification, its production and its use | |
| JP2003261559A (en) | How to make esculetin | |
| JP2004292374A (en) | Method for producing carboxylic acid halide | |
| JPH0662539B2 (en) | Method for producing 2,3-dicyano-1,4-dihydroxynaphthalene derivative | |
| JPS6213338B2 (en) | ||
| CS252794B1 (en) | A method for purifying 2,6-dichlorodiphenylamine | |
| JP2001328993A (en) | Optically active phosphine compound | |
| JP2015196668A (en) | Method for manufacturing cyanopyridine compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |
Ref document number: DK |